Cargando…
Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease
PURPOSE: In order to maximise the utility of [(11)C]-PBR28 for use in longitudinal studies and clinical trials in Alzheimer’s disease (AD), there is a need to develop non-invasive metrics of tracer binding that do not require arterial cannulation. Recent work has suggested that standardised uptake v...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039146/ https://www.ncbi.nlm.nih.gov/pubmed/27678494 http://dx.doi.org/10.1186/s13550-016-0226-3 |
_version_ | 1782455999210192896 |
---|---|
author | Nair, Akshay Veronese, Mattia Xu, Xiaohui Curtis, Charles Turkheimer, Federico Howard, Robert Reeves, Suzanne |
author_facet | Nair, Akshay Veronese, Mattia Xu, Xiaohui Curtis, Charles Turkheimer, Federico Howard, Robert Reeves, Suzanne |
author_sort | Nair, Akshay |
collection | PubMed |
description | PURPOSE: In order to maximise the utility of [(11)C]-PBR28 for use in longitudinal studies and clinical trials in Alzheimer’s disease (AD), there is a need to develop non-invasive metrics of tracer binding that do not require arterial cannulation. Recent work has suggested that standardised uptake value (SUV)-based methods may be sensitive to changes in translocator protein (TSPO) levels associated with neurodegeneration. However, the test-retest reliability of these approaches in AD over a time period relevant for clinical trials is unknown. In this study, the test-retest reliability of three SUV-based metrics was assessed in AD patients over 12 weeks. METHODS: Five patients with mild AD and the high-affinity binding TSPO genotype underwent two [(11)C]-PBR28 PET scans approximately 12 weeks apart. The test-retest reliability (TRR) of the unadjusted SUV, SUV relative to cerebellar grey matter (SUVR(C)) and SUV normalised to whole brain activity (SUVR(WB)) in nine cortical and limbic regions of interest was assessed using the absolute variability and the intraclass correlation coefficient. RESULTS: Of the three measures, SUVR(WB) performed best overall, showing low absolute variability (mean −0.13 %, SD 2.47 %) and high reliability (mean ICC = 0.83). Unadjusted SUV also performed well, with high reliability (ICC = 0.94) but also high variability (mean −1.24 %, SD 7.28 %). By comparison, the SUVR(C) showed higher variability (mean −3.98 %, SD 7.07 %) and low reliability (ICC = 0.65). CONCLUSIONS: In this AD sample, we found that SUV-derived metrics of [(11)C]-PBR28 binding showed high stability over 12 weeks. These results compare favourably with studies reporting TRR of absolute quantification of [(11)C]-PBR28. Pending further validation of SUV-based measures of [(11)C]-PBR28, semi-quantitative methods of [(11)C]-PBR28 analysis may prove useful in longitudinal studies of AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13550-016-0226-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5039146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-50391462016-10-11 Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease Nair, Akshay Veronese, Mattia Xu, Xiaohui Curtis, Charles Turkheimer, Federico Howard, Robert Reeves, Suzanne EJNMMI Res Short Communication PURPOSE: In order to maximise the utility of [(11)C]-PBR28 for use in longitudinal studies and clinical trials in Alzheimer’s disease (AD), there is a need to develop non-invasive metrics of tracer binding that do not require arterial cannulation. Recent work has suggested that standardised uptake value (SUV)-based methods may be sensitive to changes in translocator protein (TSPO) levels associated with neurodegeneration. However, the test-retest reliability of these approaches in AD over a time period relevant for clinical trials is unknown. In this study, the test-retest reliability of three SUV-based metrics was assessed in AD patients over 12 weeks. METHODS: Five patients with mild AD and the high-affinity binding TSPO genotype underwent two [(11)C]-PBR28 PET scans approximately 12 weeks apart. The test-retest reliability (TRR) of the unadjusted SUV, SUV relative to cerebellar grey matter (SUVR(C)) and SUV normalised to whole brain activity (SUVR(WB)) in nine cortical and limbic regions of interest was assessed using the absolute variability and the intraclass correlation coefficient. RESULTS: Of the three measures, SUVR(WB) performed best overall, showing low absolute variability (mean −0.13 %, SD 2.47 %) and high reliability (mean ICC = 0.83). Unadjusted SUV also performed well, with high reliability (ICC = 0.94) but also high variability (mean −1.24 %, SD 7.28 %). By comparison, the SUVR(C) showed higher variability (mean −3.98 %, SD 7.07 %) and low reliability (ICC = 0.65). CONCLUSIONS: In this AD sample, we found that SUV-derived metrics of [(11)C]-PBR28 binding showed high stability over 12 weeks. These results compare favourably with studies reporting TRR of absolute quantification of [(11)C]-PBR28. Pending further validation of SUV-based measures of [(11)C]-PBR28, semi-quantitative methods of [(11)C]-PBR28 analysis may prove useful in longitudinal studies of AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13550-016-0226-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-09-27 /pmc/articles/PMC5039146/ /pubmed/27678494 http://dx.doi.org/10.1186/s13550-016-0226-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Short Communication Nair, Akshay Veronese, Mattia Xu, Xiaohui Curtis, Charles Turkheimer, Federico Howard, Robert Reeves, Suzanne Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease |
title | Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease |
title_full | Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease |
title_fullStr | Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease |
title_full_unstemmed | Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease |
title_short | Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer’s disease |
title_sort | test-retest analysis of a non-invasive method of quantifying [(11)c]-pbr28 binding in alzheimer’s disease |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039146/ https://www.ncbi.nlm.nih.gov/pubmed/27678494 http://dx.doi.org/10.1186/s13550-016-0226-3 |
work_keys_str_mv | AT nairakshay testretestanalysisofanoninvasivemethodofquantifying11cpbr28bindinginalzheimersdisease AT veronesemattia testretestanalysisofanoninvasivemethodofquantifying11cpbr28bindinginalzheimersdisease AT xuxiaohui testretestanalysisofanoninvasivemethodofquantifying11cpbr28bindinginalzheimersdisease AT curtischarles testretestanalysisofanoninvasivemethodofquantifying11cpbr28bindinginalzheimersdisease AT turkheimerfederico testretestanalysisofanoninvasivemethodofquantifying11cpbr28bindinginalzheimersdisease AT howardrobert testretestanalysisofanoninvasivemethodofquantifying11cpbr28bindinginalzheimersdisease AT reevessuzanne testretestanalysisofanoninvasivemethodofquantifying11cpbr28bindinginalzheimersdisease |